EFTRENONACOG ALFA: 2,138 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,138
Total FAERS Reports
29 (1.4%)
Deaths Reported
379
Hospitalizations
2,138
As Primary/Secondary Suspect
21
Life-Threatening
10
Disabilities
First Report: 200609 · Latest Report: 20250924
What Are the Most Common EFTRENONACOG ALFA Side Effects?
#1 Most Reported
Haemorrhage
802 reports (37.5%)
#2 Most Reported
Haemarthrosis
196 reports (9.2%)
#3 Most Reported
Fall
151 reports (7.1%)
All EFTRENONACOG ALFA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 802 | 37.5% | 0 | 82 |
| Haemarthrosis | 196 | 9.2% | 0 | 31 |
| Fall | 151 | 7.1% | 0 | 36 |
| Contusion | 108 | 5.1% | 0 | 15 |
| Arthralgia | 104 | 4.9% | 0 | 13 |
| Traumatic haemorrhage | 93 | 4.4% | 0 | 14 |
| Limb injury | 83 | 3.9% | 0 | 8 |
| Head injury | 76 | 3.6% | 0 | 24 |
| Epistaxis | 73 | 3.4% | 0 | 11 |
| Spontaneous haemorrhage | 71 | 3.3% | 0 | 6 |
| Joint injury | 63 | 3.0% | 0 | 5 |
| Joint swelling | 62 | 2.9% | 0 | 11 |
| Pain | 61 | 2.9% | 0 | 13 |
| Muscle haemorrhage | 46 | 2.2% | 0 | 3 |
| Injury | 45 | 2.1% | 0 | 8 |
| Pain in extremity | 41 | 1.9% | 0 | 13 |
| Post procedural haemorrhage | 38 | 1.8% | 0 | 16 |
| Inappropriate schedule of product administration | 35 | 1.6% | 0 | 4 |
| Weight increased | 34 | 1.6% | 0 | 4 |
| Drug ineffective | 33 | 1.5% | 0 | 3 |
Who Reports EFTRENONACOG ALFA Side Effects? Age & Gender Data
Gender: 2.0% female, 98.0% male. Average age: 26.7 years. Most reports from: US. View detailed demographics →
Is EFTRENONACOG ALFA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2006 | 2 | 0 | 0 |
| 2012 | 5 | 0 | 4 |
| 2013 | 6 | 0 | 6 |
| 2014 | 46 | 0 | 28 |
| 2015 | 71 | 1 | 28 |
| 2016 | 94 | 2 | 38 |
| 2017 | 118 | 4 | 34 |
| 2018 | 96 | 5 | 19 |
| 2019 | 96 | 1 | 23 |
| 2020 | 58 | 2 | 12 |
| 2021 | 132 | 0 | 19 |
| 2022 | 169 | 1 | 17 |
| 2023 | 278 | 0 | 45 |
| 2024 | 219 | 0 | 34 |
| 2025 | 189 | 1 | 20 |
What Is EFTRENONACOG ALFA Used For?
| Indication | Reports |
|---|---|
| Factor ix deficiency | 1,133 |
| Haemophilia | 148 |
| Haemorrhage | 109 |
| Product used for unknown indication | 93 |
| Prophylaxis | 77 |
| Haemorrhage prophylaxis | 34 |
| Factor viii deficiency | 17 |
| Immune tolerance induction | 16 |
| Haemarthrosis | 6 |
EFTRENONACOG ALFA vs Alternatives: Which Is Safer?
EFTRENONACOG ALFA vs EGG PHOSPHOLIPIDS\GLYCERIN\MEDIUM-CHAIN TRIGLYCERIDES\SOYBEAN OIL
EFTRENONACOG ALFA vs EGG PHOSPHOLIPIDS\GLYCERIN\SOYBEAN OIL
EFTRENONACOG ALFA vs EGG PHOSPHOLIPIDS\SAFFLOWER OIL\SOYBEAN OIL
EFTRENONACOG ALFA vs ELACESTRANT
EFTRENONACOG ALFA vs ELAFIBRANOR
EFTRENONACOG ALFA vs ELAGOLIX
EFTRENONACOG ALFA vs ELAGOLIX\ESTRADIOL\NORETHINDRONE
EFTRENONACOG ALFA vs ELAPEGADEMASE-LVLR
EFTRENONACOG ALFA vs ELASOMERAN
EFTRENONACOG ALFA vs ELBASVIR
Official FDA Label for EFTRENONACOG ALFA
Official prescribing information from the FDA-approved drug label.